Illumina Nears Win In Bid To Block BGI's DNA Product Sales
A California federal judge said Monday that he's inclined to grant Illumina's preliminary bid to block China-based BGI Genomics from selling DNA sequencing products accused of infringing its patents, while BGI...To view the full article, register now.
Already a subscriber? Click here to view full article